Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Oct 27, 2025; 17(10): 105360
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.105360
Published online Oct 27, 2025. doi: 10.4240/wjgs.v17.i10.105360
Figure 1 Progression-free survival comparison between treatment groups: A Kaplan-Meier analysis.
SBRT: Stereotactic body radiation therapy.
Figure 2 Non-linear relationship between stereotactic body radiation therapy dose and survival risk.
SBRT: Stereotactic body radiation therapy; HR: Hazard ratio.
Figure 3 Subgroup analysis of stereotactic body radiation therapy dose effect on survival in liver cancer patients.
SBRT: Stereotactic body radiation therapy.
- Citation: Chen L, Wang L, Wang H. Comparison of stereotactic body radiotherapy following transcatheter arterial chemoembolization vs transcatheter arterial chemoembolization alone in hepatocellular carcinoma. World J Gastrointest Surg 2025; 17(10): 105360
- URL: https://www.wjgnet.com/1948-9366/full/v17/i10/105360.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i10.105360
